Style | Citing Format |
---|---|
MLA | Ghadiri M, et al.. "In-Vitro Assessment of Magnetic Dextran-Spermine Nanoparticles for Capecitabine Delivery to Cancerous Cells." Iranian Journal of Pharmaceutical Research, vol. 16, no. 4, 2017, pp. 1320-1334. |
APA | Ghadiri M, Vasheghanifarahani E, Atyabi F, Kobarfard F, Hosseinkhani H (2017). In-Vitro Assessment of Magnetic Dextran-Spermine Nanoparticles for Capecitabine Delivery to Cancerous Cells. Iranian Journal of Pharmaceutical Research, 16(4), 1320-1334. |
Chicago | Ghadiri M, Vasheghanifarahani E, Atyabi F, Kobarfard F, Hosseinkhani H. "In-Vitro Assessment of Magnetic Dextran-Spermine Nanoparticles for Capecitabine Delivery to Cancerous Cells." Iranian Journal of Pharmaceutical Research 16, no. 4 (2017): 1320-1334. |
Harvard | Ghadiri M et al. (2017) 'In-Vitro Assessment of Magnetic Dextran-Spermine Nanoparticles for Capecitabine Delivery to Cancerous Cells', Iranian Journal of Pharmaceutical Research, 16(4), pp. 1320-1334. |
Vancouver | Ghadiri M, Vasheghanifarahani E, Atyabi F, Kobarfard F, Hosseinkhani H. In-Vitro Assessment of Magnetic Dextran-Spermine Nanoparticles for Capecitabine Delivery to Cancerous Cells. Iranian Journal of Pharmaceutical Research. 2017;16(4):1320-1334. |
BibTex | @article{ author = {Ghadiri M and Vasheghanifarahani E and Atyabi F and Kobarfard F and Hosseinkhani H}, title = {In-Vitro Assessment of Magnetic Dextran-Spermine Nanoparticles for Capecitabine Delivery to Cancerous Cells}, journal = {Iranian Journal of Pharmaceutical Research}, volume = {16}, number = {4}, pages = {1320-1334}, year = {2017} } |
RIS | TY - JOUR AU - Ghadiri M AU - Vasheghanifarahani E AU - Atyabi F AU - Kobarfard F AU - Hosseinkhani H TI - In-Vitro Assessment of Magnetic Dextran-Spermine Nanoparticles for Capecitabine Delivery to Cancerous Cells JO - Iranian Journal of Pharmaceutical Research VL - 16 IS - 4 SP - 1320 EP - 1334 PY - 2017 ER - |